Meningeal Melanoma

subtype

Identifier: CI-CAN-00003314
Entity page: /cancer/meningeal-melanoma ↗
Edges: 8

Neighbours: 4 drugs4 trials
Drawn: 8 of 8 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Meningeal Melanoma investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Atezolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Meningeal Melanoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants

Meningeal Melanoma studied in …STUDIED_INderived4 of 4
→ studied in	NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ALIAS · 4 trials mapped (3 active)	—	—	Meningeal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07414979Phase 1 · not yet recruiting Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma · condition mapped ALIAS · 4 trials mapped (3 active)	—	—	Meningeal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03175432Phase 2 · active not recruiting Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Intracranial Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05984108unknown Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)	—	—	Meningeal Melanoma	1	Observed	clinicaltrials	graph →

Meningeal Melanoma studied in …STUDIED_INderived4 of 4

→ studied in

NCT03025256Phase 1 · active not recruiting

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ALIAS · 4 trials mapped (3 active)

—

Meningeal Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT07414979Phase 1 · not yet recruiting

Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma · condition mapped ALIAS · 4 trials mapped (3 active)

—

Meningeal Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT03175432Phase 2 · active not recruiting

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Intracranial Melanoma

Observed

clinicaltrials

graph →

→ studied in

NCT05984108unknown

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 4 trials mapped (3 active)

—

Meningeal Melanoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains